Roche commits $750m to double Oregon-based US manufacturing capacity
Roche-owned Genentech has tapped the Northwestern state of Oregon as home to a new, $750m injectable manufacturing facility – expanding its presence in the city of Hillsboro and further bolstering its presence on American soil. The Swiss pharma giant plans …